Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 725

Results For "LA"

8503 News Found

Sir H.N. Reliance Foundation Hospital performs complete robotic gastric bypass surgery
Hospitals | March 06, 2022

Sir H.N. Reliance Foundation Hospital performs complete robotic gastric bypass surgery

Dr. Muffazal Lakdawala performs the largest series of complete robotic gastric bypass surgery in India


USFDA approves expanded use of Bristol Myers Opdivo
Drug Approval | March 06, 2022

USFDA approves expanded use of Bristol Myers Opdivo

The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer


Johnson & Johnson Vision Care receives USFDA approval for drug-eluting contact lens
Drug Approval | March 06, 2022

Johnson & Johnson Vision Care receives USFDA approval for drug-eluting contact lens

Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category


Aquestive Therapeutics and Haisco Pharmaceutical partner for riluzole in China.
Biotech | March 06, 2022

Aquestive Therapeutics and Haisco Pharmaceutical partner for riluzole in China.

Around 85% of ALS patients suffer from a progressive loss of bulbar functionality


WuXi STA passes EMA drug product pre-approval inspection at its Wuxi City site
Biotech | March 04, 2022

WuXi STA passes EMA drug product pre-approval inspection at its Wuxi City site

WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms


WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP
News | March 04, 2022

WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP

Launched in 2020, C-TAP aims to facilitate timely, equitable and affordable access to Covid-19 health products by boosting their production and supply through open, non-exclusive licensing agreements


AbbVie acquires Syndesi Therapeutics, strengthening neuroscience portfolio
News | March 04, 2022

AbbVie acquires Syndesi Therapeutics, strengthening neuroscience portfolio

Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies


Known Medicine partners with Duke University to predict lung cancer response to drug treatments
Biotech | March 04, 2022

Known Medicine partners with Duke University to predict lung cancer response to drug treatments

Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer


MIBCON NDC offers CO2 Optimisation module
Sustainability | March 04, 2022

MIBCON NDC offers CO2 Optimisation module

The CO2 Optimization module is one of the four modules (Product Costing, BoM Management, CO2 Optimization, Supplier Strategy) within the entire NDC Simulation Suite


AIkido Pharma improves manufacturing process for pancreatic drug
Biotech | March 04, 2022

AIkido Pharma improves manufacturing process for pancreatic drug

The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug